Biotech companies make some of the best growth stocks.
These firms are at the forefront of medical advances such as gene editing, immunotherapy, artificial intelligence (AI)-driven drug discovery, and precision medicine. Breakthroughs in these areas can drive massive revenue growth and open up new market opportunities, resulting in a significant stock price surge. While biotech growth stocks are risky, they also have high reward potential for long-term investors willing to navigate volatility and regulatory hurdles. Here are two such growth stocks that investors may want to consider now.
